Aviso: Este sitio agrega datos públicos oficiales de la FDA, ClinicalTrials.gov, PubMed y SEC EDGAR solo como referencia general. No constituye asesoramiento médico, diagnóstico, recomendaciones de tratamiento ni asesoramiento de inversión.

PubMed

The history of state preemption and medical device regulation: lessons for artificial intelligence oversight.

PMID: 41815749 ·

C, a, s, e, , T, h, o, m, a, s, o, n, ;, , L, a, r, r, y, , B, u, c, s, h, o, n, ;, , B, r, i, a, n, , J, , M, i, l, l, e, r, ;, , B, r, i, a, n, , Y, a, g, i

RevistaHealth affairs scholar
Año
PMID41815749

Resumen

Rapid expansion of artificial intelligence (AI) in health care has outpaced the United States' fragmented regulatory structure, which currently relies on overlapping albeit incomplete federal oversight from multiple agencies. In the absence of clear federal product standards, some states have advanced broad and inconsistent regulatory schemes that often sweep AI-enabled medical devices into consumer-protection frameworks not designed for clinically used technologies. These state-level requiremen

Fuente oficial

Ver en PubMed →

Datos obtenidos de PubMed / NCBI. Para consultar el texto completo y la información más reciente, remítase siempre al registro oficial.

↑